Latest News and Press Releases
Want to stay updated on the latest news?
-
RedHill recently launched Talicia® in the U.S., calling on gastroenterologists, primary care physicians and other healthcare providers --- Talicia® is the first and only FDA-approved...
-
VANCOUVER, Washington, March 13, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5...
-
SAN JOSE, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Shuttered workplaces, canceled classes and travel restrictions combined with financial market uncertainty have created a heightened state of...
-
TORONTO, March 12, 2020 (GLOBE NEWSWIRE) -- A coalition of health professionals, represented by the Decent Work and Health Network, held a press conference today at Queen’s Park to urge the Ontario...
-
ANAHEIM, CA, March 12, 2020 (GLOBE NEWSWIRE) -- MESQUITE, NV Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce that its 51% controlled subsidiary, GK Manufacturing & Packaging, Inc....
-
Fourth Quarter 2019 Highlights Net sales decreased 5.8 percent to $91.7 million from $97.4 million in 2018GAAP net income was $1.2 million compared to a net loss of $2.8 million in the prior...
-
TORONTO, March 11, 2020 (GLOBE NEWSWIRE) -- Health professionals will hold a joint press conference with community leaders and workers’ rights advocates at Queen’s Park on Thursday, March 12 at 9:00...
-
Novavax’ proprietary Matrix-M vaccine adjuvant enhances immune response of malaria antigen developed at Jenner Institute at Oxford UniversityPhase 2b clinical efficacy study of experimental malaria...
-
Phase 2 study evaluating RedHill’s proprietary NCE1 opaganib (Yeliva®, ABC294640) in prostate cancer initiated at Medical University of South Carolina, supported by an NCI grant --- ...
-
Fourth Quarter 2019 Highlights vs. Fourth Quarter 2018 Strong growth in net sales to $13.1 million, higher gross margins, and significantly improved marketing efficiency year-over-year.Tru...